The lack of online and social media marketing guidance from the US Food and Drug Administration has prompted a group of drugmakers, marketers and Internet players to form a nonprofit coalition to help move toward consensus on standards. The Digital Health Coalition was created by Mark Bard, formerly of Manhattan Research, and includes representatives from Merck, Roche, AstraZeneca, Lilly, Sanofi, GlaxoSmithKline, Google, Epocrates, HealthCentral, and agencies Edelman and Digitas Health. “A lot of us have ideas about how the industry can evolve. Let's start that conversation,” said Bard, who recently spoke with Pharmalot’s Ed Silverman about the group’s goals and plans.
Read more: